|
⚲
|
| Preferred Income Partners IV LLC | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001457305 |
| Sale | 2009-03-01 ($50.0 M Offered, $40.7 M Sold) |
| Fund | |
| Phone | 2142348200 |
| Address | 13760 Noel Road Dallas, 75240 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Thomas Mock | |
| Kenneth Dunn | |
| Timothy Nichols | |
| Richard Cole Jr |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Quantrx Biomedical Corp
✚
|
0.0 | |
|
Pathway Private Equity Fund V-E, LP
✚
|
0.0 | |
|
Qwest Communications International Inc
✚
|
0.0 | |
|
CO-0307 Fund I, a series of Riverside Ventures, LP
✚
|
0.0 | |
|
CO-0307 Fund I, a series of Underscore Funds, LP
✚
|
0.0 | |
|
Patton Robert J
✚
|
0.0 | |
|
Paulson DermTech Investments III, LLC
✚
|
0.0 | |
|
SLU Capital, LLC
✚
|
0.0 | |
|
Smart Michael A
✚
|
0.0 | |
|
Quantified Oncology, LLC
✚
|
0.0 |